Accelerate Diagnostics
Matthew W. Strobeck, Ph.D. has served as a Director of the company since July 7, 2012. Dr. Strobeck is currently the Managing Partner of Birchview Capital. Dr. Strobeck was a Partner and Member of the Management Committee and Advisory Board of Westfield Capital Management from 2008 until 2011, having served as a member of the investment team, specializing in healthcare and life sciences, from May 2003 to June 2008. Dr. Strobeck currently serves on the Boards of Quidel Corporation, a provider of rapid diagnostic testing solutions; Tepha Inc., a medical device company; Biodesix, a private diagnostic company; and Monteris Medical, a medical device company. Dr. Strobeck received his B.S. from St. Lawrence University, a Ph.D. from the University of Cincinnati, an S.M. from the Harvard University/MIT Health Sciences Technology Program, and an S.M. from the MIT Sloan School of Management.
This person is not in the org chart
This person is not in any offices
Accelerate Diagnostics
1 followers
Fully automated antibiotic susceptibility results with MICs direct from positive blood cultures using the Accelerate Pheno™ System.